Overview

A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

Status:
COMPLETED
Trial end date:
2025-03-13
Target enrollment:
Participant gender:
Summary
This Phase I study will gather important information on the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5004 in both healthy Japanese participants and Japanese participants with T2DM.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca